Search

everythinglearnresearchcommunity

for

Search:↓

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Deleting TNFα gene reduces skin cancer risk in certain mice.

A KRT32 gene variant causes loose anagen hair syndrome.

A genetic variant in the GJB6 gene likely caused the Labrador's paw pad condition.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

A new mouse mutation causes skin and hair issues, influenced by another gene.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

FoxN1 overexpression in young mice harms immune cell and skin development.

Nitrate helps plants manage phosphate uptake and starvation responses through NIGT1 proteins.

Understanding genes and mutations can lead to new treatments for hair loss disorders.

PTHrP is important for bone formation and may be targeted for osteoporosis treatment and longevity therapies.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

A genetic change in the EDAR gene causes the unique hair traits found in East Asians.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

Activated protein C helps protect mice from long-term radiation damage.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Mutations in the SNRPE gene cause hereditary hair loss.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

RIPK1 inhibitors might help prevent alopecia areata.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

MFN2 mutations cause mitochondrial problems, leading to more upper body fat and lower leptin levels.

The PER3 rs772027021 SNP may cause mild skin pigmentation changes in a new subtype of dyschromatosis universalis hereditaria.